Sarepta Therapeutics, Inc. (SRPT) › RevenueSarepta Therapeutics, Inc. (SRPT) — RevenueAnnual figures by fiscal year, from SEC filings.2014: $9.76M2015: $1.25M2016: $5.42M2017: $154.58M2018: $301.03M2019: $380.83M2020: $540.10M2021: $701.89M2022: $933.01M2023: $1.24B2024: $1.90B2025: $2.20B$2.20B2014Revenue (USD)2025Fiscal YearRevenueChange YoY2025$2.20B+15.6%2024$1.90B+53.0%2023$1.24B+33.3%2022$933.01M+32.9%2021$701.89M+30.0%2020$540.10M+41.8%2019$380.83M+26.5%2018$301.03M+94.7%2017$154.58M+2751.6%2016$5.42M+332.6%2015$1.25M-87.2%2014$9.76M—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share